Related references
Note: Only part of the references are listed.Clinical Risk and Overall Survival in Patients with Diabetes Mellitus, Hyperglycemia and Glioblastoma Multiforme. A Review of the Current Literature
Nicola Montemurro et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Routine Blood Tests Do Not Predict Survival in Patients with Glioblastoma-Multivariable Analysis of 497 Patients
Sybren L. N. Maas et al.
WORLD NEUROSURGERY (2019)
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for a Cost-Effective and Dynamic Biomarker
Giacomo Pelizzari et al.
CANCERS (2019)
Pretreatment neutrophil-to-lymphocyte ratio plus albumin-to-gamma-glutamyl transferase ratio predict the diagnosis of grade III glioma
Zhen-Qiang He et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies
Nikolaus B. Wagner et al.
BRITISH JOURNAL OF CANCER (2018)
Predictors of Prolonged Hospitalizations in Pediatric Complicated Pneumonia
Oded Breuer et al.
CHEST (2018)
Do Selected Blood Inflammatory Markers Combined with Radiological Features Predict Proliferation Index in Glioma Patients?
Yinlun Weng et al.
WORLD NEUROSURGERY (2018)
Predictive value of LDH kinetics in bevacizumab treatment and survival of patients with advanced NSCLC
Butuo Li et al.
ONCOTARGETS AND THERAPY (2018)
Viral infection in community acquired pneumonia patients with fever: a prospective observational study
Ru-Jia Tao et al.
JOURNAL OF THORACIC DISEASE (2018)
Correlation between clinical features, high-resolution computed tomography findings, and a visual scoring system in patients with pneumonia due to Mycoplasma pneumoniae
Takeshi Saraya et al.
RESPIRATORY INVESTIGATION (2018)
Long non-coding RNA LINK-A promotes glioma cell growth and invasion via lactate dehydrogenase A
Dejun Wu et al.
ONCOLOGY REPORTS (2017)
Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival
Peng-Fei Wang et al.
ONCOTARGET (2017)
Exploring the role of inflammation in the malignant transformation of low-grade gliomas
Nicole Michelson et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma
Su Hu et al.
ONCOTARGET (2016)
Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma
Sheng Han et al.
BMC CANCER (2015)
Lactate Dehydrogenase as a Biomarker for Prediction of Refractory Mycoplasma pneumoniae Pneumonia in Children
Aizhen Lu et al.
RESPIRATORY CARE (2015)
Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy
Faruk Tas et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression
Mairead G. McNamara et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and Notch signalling
Xun Jin et al.
BRAIN (2012)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 20052009
Therese A. Dolecek et al.
NEURO-ONCOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas
Andres Server et al.
EUROPEAN JOURNAL OF RADIOLOGY (2011)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
Thierry Gorlia et al.
LANCET ONCOLOGY (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Glitazones differentially regulate primary astrocyte and glioma cell survival -: Involvement of reactive oxygen species and peroxisome proliferator-activated receptor-γ
JM Pérez-Ortiz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Share Paper
